Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from ALT

Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH Trial

Altimmune (NASDAQ:ALT) executives said the company is preparing to begin enrolling patients in the second half of the year for a Phase 3 trial of pemvidutide in metabolic dysfunction-associated steatohepatitis, or MASH, while also awaiting data from related alcohol-associated liver disease programs.

MarketBeat · Jun 5

Altimmune Q1 Earnings Call Highlights

Altimmune (NASDAQ:ALT) said it has strengthened its balance sheet and is preparing to begin a global Phase 3 trial of pemvidutide in metabolic dysfunction-associated steatohepatitis, or MASH, in the second half of 2026, as the company reported first-quarter financial results and provided updates acr

MarketBeat · May 13

Rockstar celebrates official GTA mod support by nuking non-official mod platform

Can't we all just get along?

PC Gamer · Feb 17

From analysis to the latest developments in health,
read the most diverse news in one place.

After 9 years of work, team behind GTA 5 multiplayer mod that rivalled Rockstar-owned FiveM says Take-Two is shutting the project down: "Thank you for being part of this journey"

Support for Alt:V will end by early July

GamesRadar · Feb 10

Away from the headlines – the Cycling Weekly team's alternative riders of 2025

Recognition for those riders who deserve more attention than they have received

Cycling Weekly · Dec 29, 2025

These Analysts Slash Their Forecasts On Altimmune Following Q2 Results

Altimmune, Inc. (NASDAQ:ALT) posted a loss for the second quarter on Tuesday.

Benzinga · Aug 13, 2025

Altimmune Q2 FY2025 Earnings Call Transcript

Altimmune, Inc. (NASDAQ:ALT) reported its second-quarter financial results before Tuesday’s opening bell.

Benzinga · Aug 12, 2025

Read news from The Economist, FT, and more,
with one subscription

Altimmune, Bit Digital, Kratos Defense & Security Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Thursday.

Benzinga · Jun 26, 2025

woman&home Easter Food Awards 2025: Best Easter Rosé

Add a little splash of something special to your Easter treats with our expert-picked range of rosé wines and Prosecco

Woman & Home · Feb 21, 2025

Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Wednesday.

Benzinga · Dec 4, 2024

Biden Administration Imposes Sanctions On Georgian Officials

Biden administration imposes sanctions on Georgian officials for undermining democracy and violating human rights.

Top News · Sep 16, 2024

2 Small-Cap Stocks Under $20 With Over 220% Upside Potential

Wall Street is forecasting multibagger returns from these two small-cap biotech stocks over the next year.

Barchart · Aug 4, 2024

What is Surfshark's Alternative ID

Surfshark's Alternative ID allows you to shore up your online privacy by creating a fictitious identity for one-off uses.

Tom’s Guide · Jun 28, 2024

“We ended up at Robert Pattinson’s house with Rami Malek!": Alt-J on the wildest night out they've ever had

The indie-rock trio partied with Batman and a Bond villain...

Louder · Feb 24, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

Al Jazeera · Jan 17, 2024

Death threats for a Stalin vandal prompt soul-searching in Orthodox Georgia

An icon featuring Joseph Stalin on display inside Georgia’s largest cathedral causes a furore.

Fortune · Jul 13, 2023

Big Finance is taking over Big Sports. From Josh Harris to Steve Cohen to David Blitzer, here are the 120 ‘alt’ power players entering the field of play

An analysis by Fortune shows that roughly 120 private equity, VC, and hedge fund execs have amassed stakes in big-time sports franchises.

The Hindu · Apr 26, 2023

Alt.Pizza restaurant review: When bread meets cheese

From sourdough pizza crusts to reconstructed chocolate bars, Alt.Pizza, the Singapore-based pizza chain, offers an alternate take on fan favourites in its Bengaluru outlet

Chicago Sun-Times · Oct 10, 2022

Artist collective raises $350K to invest in West Side

alt_ (you can call them “Alt Space”) plans to put the money to work on education and beautification projects, among other things.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Sep 14, 2022

Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ:TCON) lead asset envafolimab (KN035) for patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) who have progressed on one or two prior lines of chemotherapy. TRACON shares…

Benzinga · Sep 14, 2022

Dow, S&P 500 Turn Lower; Altimmune Shares Slide

U.S. stocks pared gains toward the end of trading, with the Dow Jones dropping around 80 points on Wednesday.

Benzinga · Sep 13, 2022

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

The National (Scotland) · Jul 30, 2022

Clare Grogan makes a return as the queen of pop with Altered Images

CLARE Grogan was starring in Neil Simon’s rom-com Barefoot In the Park at the 2020 Pitlochry Festival Theatre when lockdown kicked in.

The Hindu · Jul 1, 2022

High Court issues notice to Delhi Police on Alt News co-founder Mohammed Zubair’s plea against police remand

NEW DELHI

Benzinga · May 12, 2022

Altimmune: Q1 Earnings Insights

Altimmune (NASDAQ:ALT) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga · Mar 16, 2022

Altimmune Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data, during Q4, Altimmune (NASDAQ:ALT) posted sales of $3.28 million. Earnings were up 28.71%, but Altimmune still reported an overall loss of $23.89 million.

1 2

Coverage From

People

Pauline FerrandPrévot

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.